ML16083A107: Difference between revisions
From kanterella
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 14: | Line 14: | ||
| document type = Meeting Summary | | document type = Meeting Summary | ||
| page count = 5 | | page count = 5 | ||
| revision = 0 | |||
}} | }} | ||
Revision as of 21:21, 25 February 2018
Letter Sequence Meeting | |
|---|---|
TAC:MF6138, (Open) | |
Initiation Administration | |
MONTHYEARML16344A0552015-08-29029 August 2015
[Table View]NWMI-2015-CSE-008, Nwmi Preliminary Criticality Safety Evaluation: Hot Cell Uranium Purification (Recovery and Recycle) (Rev. a) (Public Version) Project stage: Other ML16048A5542016-02-17017 February 2016 Rev 9 Mo-99 Overview and Status Slides No Notes Project stage: Request ML16083A1062016-02-18018 February 2016 Transcript of Public Meeting with Northwest Medical Isotopes on February 18, 2016, Pages 1-176 Project stage: Request ML16083A1072016-03-29029 March 2016 February 18, 2016 Summary of Public Meeting with Northwest Medical Isotopes Project stage: Meeting ML16123A1192016-04-25025 April 2016 Northwest Medical Isotopes, LLC - Responses to the NRC Environmental Request for Additional Information - Letter Dated March 28, 2016 Project stage: Request ML16210A3052016-07-18018 July 2016 Northwest Medical Isotopes, LLC, Response to Request for Additional Information Regarding Chapters 4, 13, and 19 of the Preliminary Safety Analysis Report and Environmental Review Project stage: Response to RAI ML16270A3772016-09-0101 September 2016 Northwest Medical Isotopes, LLC, Response to Environmental Request for Additional Information - Additional Clarification on POSA3-1A, POSA3-2A, POSA3-3A, NOI3-IB, and PA3-1 Project stage: Request ML16344A0522016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information Project stage: Request ML16344A0532016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Response to the U.S. Nuclear Regulatory Commission Request for Additional Information Regarding the Preliminary Safety Analysis Report and Environmental Review Project stage: Request ML16344A0542016-11-28028 November 2016 NWMl-2014-RPT-006, Northwest Medical Isotopes, LLC - MCNP 6.1 Validations with Continuous Energy ENDF/B-VII.1 Cross-Sections (Rev. 0) (Public Version) Project stage: Other ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 Project stage: Request ML17069A4082017-03-29029 March 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) Project stage: Request ML17128A0672017-04-28028 April 2017 NWMI-2017-RAI-002, Rev. 0, Response to the U.S. Nuclear Regulatory Commission Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Application for Construction Permit (TAC MF6138). Project stage: Request ML17157B4112017-06-0202 June 2017 Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections Project stage: Request ML17221A2012017-08-0505 August 2017 Attachment 3 to NWMI-2013-021, Rev. 2, Chapter 6.0 - Engineered Safety Features Construction Permit Application for Radioisotope Production Facility to Chapter 11.0 - Radiation Protection and Waste Management Project stage: Request ML17265A0472017-09-19019 September 2017 Response to the U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC - Request for Additional Information Regarding Preliminary Safety Analysis Report, Construction Permit Application Project stage: Request ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit Project stage: Request ML17262A1112017-09-21021 September 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML17283A1092017-09-28028 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 Project stage: Request 2016-09-01 |
| ML16083A107 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 03/29/2016 |
| Revision: | 0 |
| From: | Balazik M F NRC/NRR/DPR/PRLB |
| To: | |
| Shared Package | |
| ML16083A110 | List: |
| References | |
| TAC MF6138 | |
| Download: ML16083A107 (5) | |
Similar Documents at Northwest Medical Isotopes | |
|---|---|
Category:Meeting Summary
MONTHYEARML17061A1552017-03-27027 March 2017
[Table view]Summary of November 10, 2016, Public Meeting with Northwest Medical Isotopes, LLC ML17003A1492017-01-0303 January 2017 December 6, 2016 - Summary of Public Meeting Nwmi Deis ML16145A0182016-06-15015 June 2016 Summary of Teleconference Meeting with Northwest Medical Isotopes, LLC, on Clarifications on Responses to Request for Additional Information for Environmental Review of the Northwest Medial Isotopes Construction Application ML16110A2532016-05-12012 May 2016 April 14, 2016, Summary of Telephone Conference Call Held Between the U.S. Nuclear Regulatory Commission and Northwest Medical Isotopes, LLC Concerning Clarifications on Responses to Request for Additional Information for the Environmental ML16104A0432016-04-27027 April 2016 March 31, 2016, Summary of Telephone Conference Call Held Between the U.S. Nuclear Regulatory Commission and Northwest Medical Isotopes, LLC ML16083A1072016-03-29029 March 2016 February 18, 2016 Summary of Public Meeting with Northwest Medical Isotopes ML15356A1262016-01-20020 January 2016 Summary of Public Scoping Meeting Conducted Related to the Review of the Proposed Northwest Medical Isotopes, LLC Radiosotope Production Facility 2017-03-27 |
Retrieved from "https://kanterella.com/w/index.php?title=ML16083A107&oldid=347157"